06/23/22 4:54 PMNYSE : BHC managementBausch Health Announces 2022 Annual Meeting of Shareholder Results, Updates to its Board of DirectorsBausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced the results of its 2022 annual meeting of shareholders and certain other updates with respect to the Company's Board of Directors (the "Board").Annual MeetingRHEA-AIneutral
06/21/22 7:00 AMNYSE : BHC Bausch Health Issues Form 8-K for 2022 Annual Meeting of Shareholders PresentationBausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced the Company is providing a presentation on its business during the Company's Annual Meeting of Shareholders on June 21, 2022. The presentation will be availableRHEA-AIneutral
06/20/22 7:00 AMNYSE : BHC clinical trialSalix to Share New Data from XIFAXAN® (Rifaximin) Clinical Research at EASL's International Liver Congress™ 2022Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment ofRHEA-AIneutral
06/16/22 5:30 PMNYSE : BHC Bausch Health Provides Update on Solta MedicalBausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced an update on its previously stated plan to pursue an initial public offering (IPO) of its Solta Medical business ("Solta"). Solta is a leading global provider inRHEA-AIpositive
05/18/22 7:00 AMNYSE : BHC Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest specialtyRHEA-AIneutral
05/12/22 6:05 PMNasdaq : PACW, KBRA, BHC KBRA Releases U.S. Bank 1Q22 CompendiumThe Compendium provides our latest view of the U.S. banking sector and analyzes the 1 Q22 results of U.S. banks with KBRA long-term ratings. In addition, the Compendium includes our quarterly environmental, social, and governance Bulletin, which features PacWest Bancorp. The Compendium includes 1 Q22 summaries on all publicly traded U.S. banks in KBRA’ s rated...RHEA-AIneutral
05/11/22 7:00 AMNYSE : BHC conferencesBausch Health Announces Participation In Upcoming Investor ConferencesBausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that the Company will participate in several upcoming investor conferences.Tom Vadaketh, executive vice president and chief financial officer; William Woodfield,RHEA-AIneutral
05/10/22 12:46 PMNYSE : BHC, BLCO IPOofferingBausch Health And Bausch + Lomb Corporation Announce Closing Of Initial Public Offering Of Bausch + Lomb And Related Debt TransactionsBausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb") and Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") today announced the closing of the initial public offering ("IPO") of Bausch + Lomb. A wholly owned subsidiary ofRHEA-AIvery positive
05/10/22 6:59 AMNYSE : BHC Bausch Health Companies Inc. Announces First-Quarter 2022 ResultsFirst-Quarter 2022 Financial Results Revenues of $1.918 Billion GAAP Net Loss of $69 Million Adjusted EBITDA (non-GAAP) 1 of $732 Million Bausch + Lomb Commences Trading Under "BLCO" Ticker Following IPO 2 Updates Full-Year Revenue and Adjusted EBITDA (non-GAAP) 1 Guidance Ranges LAVAL, QC, May 10,RHEA-AIneutral
05/06/22 12:08 PMNYSE : BHC Bausch Health Announces Thomas J. Appio As Chief Executive OfficerBausch Health Companies Inc. (NYSE/TSX: BHC) (Bausch Health) today announced its full leadership team and Board of Directors, including Chief Executive Officer (CEO) Thomas J. Appio. 1 Upon completion of the initial public offering (IPO) of the Bausch + LombRHEA-AIvery positive